Barclays PLC Alkermes Plc. Put Options Transaction History

Barclays PLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2020 May 13, 2020	SELL	$13.06 - $21.24 $271,648 - $441,791	-20,800 Reduced 63.22%	12,100 $174,000
Q4 2019 Feb 10, 2020	BUY	$17.29 - $21.74 $406,315 - $510,889	23,500 Added 250.0%	32,900 $671,000
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $19,510 - $24,280	-1,000 Reduced 9.62%	9,400 $183,000
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $113,791 - $197,849	5,300 Added 103.92%	10,400 $234,000
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $42,600 - $54,735	-1,500 Reduced 22.73%	5,100 $186,000
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $92,202 - $147,213	3,300 Added 100.0%	6,600 $195,000
Q3 2018 Nov 14, 2018	SELL	$38.6 - $46.12 $19,300 - $23,060	-500 Reduced 13.16%	3,300 $140,000
Q2 2018 Aug 14, 2018	BUY	$40.56 - $51.36 $20,280 - $25,680	500 Added 15.15%	3,800 $156,000
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $868,482 - $1.09 Million	-16,200 Reduced 83.08%	3,300 $191,000
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $624,739 - $725,609	13,100 Added 204.69%	19,500 $1.07 Million
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $314,624 - $348,480	6,400	6,400 $325,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.87B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.